Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Camrelizumab 200mg will be given every 3 weeks for 3 cycles started on day 1 of induction chemotherapy and every 2 weeks for 9 cycles thereafter.

Gemcitabine 1g/m2, d1 \& 8 of every cycle, every 3 weeks for 3 cycles before radiation

Induction cisplatin 80mg/m2, every 3 weeks for 3 cycles before radiation

Definitive intensity-modulated radiotherapy (IMRT) of 6996cGy will be given in 33 fractions.

Concurrent cisplatin 100mg/m2, every 3 weeks for 2 cycles during radiation